Follicular and endocrine dose responses according to anti‐Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH ( FE 999049)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Follicular and endocrine dose responses according to anti‐Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH ( FE 999049)

Published:2015-09-03 Issue:6 Volume:83 Page:902-912
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Bosch Ernesto¹,Nyboe Andersen Anders²,Barri Pedro³,García‐Velasco Juan Antonio⁴,Sutter Petra⁵,Fernández‐Sánchez Manuel⁶,Visnova Hana⁷,Klein Bjarke M.⁸,Mannaerts Bernadette⁹,Arce Joan‐Carles⁹

Affiliation:

1. IVI Valencia Valencia Spain

2. Fertility Clinic Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

3. IU Dexeus Barcelona Spain

4. IVI Madrid Madrid Spain

5. Universitair Ziekenhuis Gent Belgium

6. IVI Sevilla Sevilla Spain

7. IVF CUBE SE Prague Czech Republic

8. Global Biometrics Global Clinical & Non‐Clinical R&D Ferring Pharmaceuticals A/S Copenhagen Denmark

9. Reproductive Health Global Clinical & Non‐Clinical R&D Ferring Pharmaceuticals A/S Copenhagen Denmark

Funder

Ferring Pharmaceuticals

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.12864

Reference28 articles.

1. Genetic engineering of human FSH (Gonal-F(R))

2. Clinical outcome of a pilot efficacy study on recombinant human follicle‐stimulating hormone (Org 32489) combined with various gonadotrophin‐releasing hormone agonist regimens;Devroey P.;Human Reproduction,1994

3. Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis

4. The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization

5. Is there a recommended maximum starting dose of FSH in IVF?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pregnancy outcomes among women receiving individualized algorithm dosing with follitropin delta: a systematic review of randomized controlled trials;Journal of Assisted Reproduction and Genetics;2024-05-29

2. BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle;Human Reproduction;2024-05-09

3. Follitropin delta combined with menotropin in patients at risk for poor ovarian response during in vitro fertilization cycles: a prospective controlled clinical study;Reproductive Biology and Endocrinology;2024-01-02

4. Follitropin delta combined with menotropin in patients at risk for poor ovarian response during in vitro fertilization cycles: a prospective controlled clinical study;2023-10-23

5. A Narrative Review Discussing the Efficiency of Personalized Dosing Algorithm of Follitropin Delta for Ovarian Stimulation and the Reproductive and Clinical Outcomes;Diagnostics;2023-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3